Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: Results from a pharmacodynamics analysis

Hamacher T., Airaksinen J., Saarela V., Liinamaa M.J., Richter U., Ropo A.

2008
Acta Ophthalmologica

View publication

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

Augenzentrum Dr Hamacher Praxis, Maximilianstrasse 2B D-82319, Starnberg, Germany; Department of Ophthalmology, Oulu University Hospital, Oulu, Finland; Private Practice, Regensburg, Germany; Department of Clinical Research, Santen Oy, Helsinki, Finland

Related Publications

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

View all Glaucoma publications